S70 Resurrection of Glucagon in Diabetes

Program: Symposia
Basic/Translational Session
Sunday, March 8, 2015: 11:15 AM-12:45 PM
Room 28C (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Novo Nordisk Inc.

Chair:
Kieren James Mather, MD, BSC, Indiana University School of Medicine, Indianapolis, IN

Disclosures:
KJM: Clinical Researcher, Novo Nordisk, Clinical Researcher, Sanofi, Clinical Researcher, Merck & Co..
11:15 AM
Roger H Unger, UT Southwestern Medical Center, Dallas, TX
Nothing to Disclose: RHU
11:45 AM
David H Wasserman, PhD, Molecular Physiology and Biiophysics, Vanderbilt University, Nashville, TN
Nothing to Disclose: DHW
12:15 PM
Richard Edwin Pratley, MD, Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL
Disclosure: REP: Speaker, Boehringer-Ingelheim, Consultant, Boehringer-Ingelheim, Consultant, Eisai, Investigator, Gilead Sciences, Investigator, GlaxoSmithKline, Consultant, GlaxoSmithKline, Consultant, ICON Clinical Research, Inc., Consultant, Jansen Pharmaceuticals, Consultant, Lexicon Pharmaceuticals, Inc., Consultant, Ligand Pharmaceuticals, Inc., Investigator, Lilly USA, LLC, Consultant, Lilly USA, LLC, Investigator, Mannkind, Consultant, Mannkind, Investigator, Merck & Co., Speaker, Merck & Co., Consultant, Merck & Co., Investigator, Novo Nordisk, Speaker, Novo Nordisk, Consultant, Novo Nordisk, Consultant, ONO-Pharma, Investigator, Pfizer, Inc., Consultant, Profil Institute, Consultant, Sanofi, Investigator, Takeda, Speaker, Takeda, Consultant, Takeda.
See more of: Symposia